Variability of cardioinhibition in vasovagal syncope: differences between subgroups during cardioinhibition and

Ineke A van Rossum1, Frederik J de Lange2, David G Benditt3

  • 1Department of Neurology, Leiden University Medical Centre, PO Box 9600, 2300, Leiden, The Netherlands. i.a.van_rossum@lumc.nl.

Insights

Individuals with marked cardioinhibition experience a faster and larger heart rate drop during vasovagal syncope. These hemodynamic differences are evident before the syncope event begins.

Area of Science:

  • Cardiology
  • Autonomic Nervous System Function

Background:

  • Vasovagal syncope involves a complex interplay of neural and cardiovascular factors.
  • Cardioinhibition, a key component, manifests as a significant heart rate decrease during syncope.
  • Understanding variations in cardioinhibition severity is crucial for patient management.

Purpose of the Study:

  • To compare hemodynamic parameters in individuals with varying degrees of cardioinhibition during vasovagal syncope.
  • To investigate whether hemodynamic differences precede the onset of cardioinhibition.

Main Methods:

  • 149 subjects experiencing vasovagal syncope during tilt-table testing were included.
  • Subjects were categorized into marked, intermediate, and minimal cardioinhibition groups based on heart rate decrease.
  • Hemodynamic parameters were assessed in supine, post-tilt, and cardioinhibitory phases.

Main Results:

  • Subjects with marked cardioinhibition exhibited higher heart rates before and during syncope compared to other groups.
  • The heart rate decrease was significantly larger and more rapid in the marked cardioinhibition group.
  • Hemodynamic profiles differed among groups even before the tilt maneuver.

Conclusions:

  • Marked cardioinhibition is characterized by a more pronounced and accelerated heart rate reduction.
  • Pre-existing hemodynamic variations contribute to the development of marked cardioinhibition.
  • These findings highlight distinct physiological profiles associated with different severities of cardioinhibition.
Abstract

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.9K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
929
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
14
Dysrhythmias III: Characteristics of Dysrhythmias01:29

Dysrhythmias III: Characteristics of Dysrhythmias

Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per...
11
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
7